Market Introduction
Vitrectomy is a surgical procedure employed to treat various problems with the retina and vitreous and remove the vitreous gel from the eye. It is performed during retinal detachment with vitreous hemorrhage. As a result, this smoothens the procedure and prevents any further detachment of the retina. In addition, it is helpful for various repairs, such as the removal of scar tissue. It helps restore the vision loss caused due to vitreous humor bleeding.
Moreover, the significant advancements related to vitreoretinal surgery devices are expected to bolster the market growth during the forecast period. However, complications associated with vitrectomy limit the growth of the Asia Pacific vitrectomy devices market.
Countries such as Japan and Australia are conducting virtual international conferences to anticipate the impact of COVID-19 on medical device industry in the Asia Pacific. The ongoing COVID-19 pandemic has created a seismic shift in living habits in the region and medical device industry has borne a significant brunt of this shopper shake-up. China is specifically facing issues with the pandemic, leading to disruption of the supply chain, projected losses in revenue, marketing and sales within all industries, as well as the concerns of health within the production units and other public places. On the other hand, unlike to North America and Europe as of now Asian countries have not imposed second lockdown. Hence, the businesses in the countries are slowly recovering their economies. Urban areas are experiencing adjusting to a changing market. Thus, owing to these it is likely to have opportunities for the market to bring its economy on track.
Market Overview and Dynamics
The Asia Pacific vitrectomy devices market is expected to reach US$ 408.9 million by 2028 from US$ 250.6 million in 2021. The market is estimated to grow at a CAGR of 7.2% from 2021–2028. The small-gauge cutter and improved illumination systems are two of the most significant developments in this field. Transconjunctival sutureless small-gauge PPV is a safe and successful alternative to conventional 20-gauge PPV for a range of vitreoretinal disorders. Similarly, Chandelier illumination enables greater vitreous visibility during bimanual surgery. The small-gauge PPV has advantages in reduced inflammation, patient discomfort, and faster visual acuity recovery. As a result, significant developments in vitreoretinal surgical instruments are propelling market expansion. There have been considerable advancements in vitrectomy cutters over the past few years, leading to improvement in vitreoretinal surgery devices, which is driving the market significantly.
Key Market Segments
In terms of product, the vitrectomy machines segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020. In terms of patient type, the geriatric segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020. In terms of surgery approach, the posterior/pars plana vitrectomy segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020. In terms of application, the diabetic retinopathy segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020. In terms of distribution channel, the retail sales segment accounted for the largest share of the Asia Pacific vitrectomy devices market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the vitrectomy devices market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are D.O.R.C Dutch Ophthalmic Research Center (International)B. V, HOYA Corporation, NIDEK CO., LTD, Danaher (Leica Microsystems AG), Carl Zeiss Meditec, Alcon Inc., Iridex Corporation, Bausch Health Companies Inc., Topcon Corporation, GEUDER AG, and Optos.
Reasons to Buy Report
ASIA PACIFIC VITRECTOMY DEVICES MARKET SEGMENTATION
By Product
By Patient Type
By Surgery Approach
By Application
By End User
By Distribution Channel
By Country
Companies Mentioned
Strategic insights for the Asia Pacific Vitrectomy Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 250.6 Million |
Market Size by 2028 | US$ 408.9 Million |
Global CAGR (2021 - 2028) | 7.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
The geographic scope of the Asia Pacific Vitrectomy Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Asia Pacific Vitrectomy Devices Market is valued at US$ 250.6 Million in 2021, it is projected to reach US$ 408.9 Million by 2028.
As per our report Asia Pacific Vitrectomy Devices Market, the market size is valued at US$ 250.6 Million in 2021, projecting it to reach US$ 408.9 Million by 2028. This translates to a CAGR of approximately 7.2% during the forecast period.
The Asia Pacific Vitrectomy Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Vitrectomy Devices Market report:
The Asia Pacific Vitrectomy Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Vitrectomy Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Vitrectomy Devices Market value chain can benefit from the information contained in a comprehensive market report.